Top-News

Charlottes Web Aktie News

Aktie
WKN:  A2N434 ISIN:  CA16106R1091 US-Symbol:  CWBHF Branche:  Pharmazeutika Land:  USA
0,064 €
-0,0065 €
-9,22%
08:05:05 Uhr
Depot/Watchlist
Marktkapitalisierung *
12,76 Mio. €
Streubesitz
96,24%
KGV
-0,47
Index-Zuordnung
-

Charlottes Web News

12.11.25 - PR Newswire
Charlotte's Web Reports Q3 2025 Results
Charlotte's Web Reports Q3 2025 Results PR Newswire
21.10.25 - PR Newswire
Charlotte's Web Appoints M. Borgia Walker to Board of Directors
Charlotte's Web Appoints M. Borgia Walker to Board of Directors PR Newswire
14.10.25 - PR Newswire
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies
Charlotte's Web™ Expands its Brightside Line with Launch of Knockout Hemp THC Sleep Gummies PR Newswire
30.09.25 - PR Newswire
Charlotte's Web™ Expands Sleep Category with Launch of Quiet Sleep Mushroom Gummies
Charlotte's Web™ Expands Sleep Category with Launch of Quiet Sleep Mushroom Gummies PR Newswire
04.09.25 - PR Newswire
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board
Charlotte's Web Announces Plans to Establish a Scientific Advisory Board PR Newswire
13.08.25 - PR Newswire
Charlotte's Web Reports Year-Over-Year Growth For Q2 2025
Charlotte's Web Reports Year-​Over-Year Growth For Q2 2025 PR Newswire
05.08.25 - PR Newswire
Charlotte's Web 2025 Second Quarter Earnings Call and Webcast Notice
Charlotte's Web 2025 Second Quarter Earnings Call and Webcast Notice PR Newswire
13.06.25 - PR Newswire
Charlotte's Web Reports Shareholder Meeting Voting Results
Charlotte's Web Reports Shareholder Meeting Voting Results PR Newswire
27.05.25 - PR Newswire
Charlotte's Web™ Unveiling Brightside™ Precision-Formulated Approach to Hemp-Derived THC at Benzinga Conference
Charlotte's Web™ Unveiling Brightside™ Precision-​Formulated Approach to Hemp-​Derived THC at Benzinga Conference PR Newswire
14.05.25 - PR Newswire
Charlotte's Web Reports Year-Over-Year Growth For Q1 2025
Charlotte's Web Reports Year-​Over-Year Growth For Q1 2025 PR Newswire
19.03.25 - PR Newswire
Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results
Charlotte's Web Reports 2024 Fourth Quarter and Year-End Financial Results PR Newswire
25.02.25 - PR Newswire
Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice
Charlotte's Web 2024 Fourth Quarter Earnings Call and Webcast Notice PR Newswire
24.02.25 - PR Newswire
Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment
Charlotte's Web Announces DeFloria to enter Phase 2 FDA Clinical Trial for Autism Spectrum Disorder Treatment PR Newswire
24.02.25 - PR Newswire
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism Spectrum Disorder (ASD)
DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of ...
12.12.24 - PR Newswire
Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder
Charlotte's Web Provides Update on DeFloria's Phase 1 Results Targeting Autism Spectrum Disorder PR Newswire

Newssuche

Videos

newspaper
10:40 Uhr -2,34%
Technical Trading: Zucker Long zum Jahresende
Zucker Long Typ: Turbo Open End WKN: VP89SL Hebel: 5,88 Laufzeit: OpenEnd Einstieg: Market ... Mehr »